Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer

NCT03029533 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Leuprolide Acetate
DRUG: Leuprolide Acetate

Sponsor

Daewoong Pharmaceutical Co. LTD.